share_log

MARC Affirms Sunway Healthcare AA Ratings On Its RM5 Billion Sukuk

MARC Affirms Sunway Healthcare AA Ratings On Its RM5 Billion Sukuk

MARC確認Sunway Healthcare的AA評級,基於其50億馬幣的Sukuk
Business Today ·  2024/12/13 17:07
big

MARC Ratings has affirmed its rating of AAIS(cg) on Sunway Healthcare Treasury Sdn Bhd's (SH Treasury) Islamic Medium-Term Notes (Sukuk Wakalah) Programme of up to RM5.0 billion with a Stable outloo.

MARC評級確認了對信威醫療財資私人有限公司(上海國庫)伊斯蘭中期票據(Sukuk Wakalah)計劃的AAIS(cg)評級,最高爲50令吉,前景穩定。

The agency said the rating reflects the credit strength of parent Sunway Healthcare Holdings Sdn Bhd (SHH), based on SHH's unconditional and irrevocable guarantee on the programme.

該機構表示,根據SHH對該計劃的無條件和不可撤銷的擔保,該評級反映了母公司Sunway Healthcare Holdings Sdn Bhd(SHH)的信用實力。

The affirmed rating reflects SHH's strengthening business profile with a growing market share in the Malaysian healthcare sector and strong debt service ability given its robust internal cash flow generation. SHH's healthy liquidity position and strong financial flexibility supported by a strong ownership profile are also key rating factors. These factors are tempered by execution risk associated with the group's rapid expansion plans, its exposure to regulatory and contingent liabilities, and concerns over the industry-wide shortage of nurses.

確認的評級反映了SHH的業務形象不斷增強,在馬來西亞醫療保健領域的市場份額不斷增加,並且由於其強大的內部現金流產生,還本付息能力強。SHH健康的流動性狀況和強大的財務靈活性以及強大的所有權狀況也是關鍵的評級因素。與集團快速擴張計劃相關的執行風險、其監管和或有負債敞口以及對全行業護士短缺的擔憂,抑制了這些因素。

The group has strengthened its position as a key player in the domestic private healthcare industry. As of September 2024, SHH operates three hospitals with 1,240 licensed beds (end-2023: 1,148 beds), capturing an estimated 7% of the market based on bed count. With two new hospitals opening from 4Q2024 and ongoing expansions, total bed capacity is expected to increase to around 1,900. This, along with strong industry growth drivers, will provide further upside to the group's operational and financial profiles. As of July 2024, SHH's patient throughput reached 741,000 and is on track to surpass the 1.2 million visits recorded in 2023.

該集團鞏固了其作爲國內私人醫療保健行業關鍵參與者的地位。截至2024年9月,SHH經營三家醫院,擁有1,240張許可牀位(2023年底:1,148張牀位),根據牀位數,估計佔據了7%的市場份額。隨着兩家新醫院從 4Q2024 開始開放以及持續擴建,總牀位容量預計將增加到大約 1,900 張。再加上強勁的行業增長動力,將爲該集團的運營和財務狀況提供進一步的上行空間。截至2024年7月,SHH的患者吞吐量達到74.1萬人次,並有望超過2023年記錄的120萬次就診量。

Revenue for 2024 is likely to chart higher than the RM1.5 billion posted in 2023 based on strong 9M2024 results. The solid top-line performance has supported EBITDA growth and strong cash generation. The group projects to generate RM480 million to RM1.2 billion of annual cash flow from operations between 2025 and 2030, supported by portfolio growth.

根據強勁的 9M2024 業績,2024年的收入可能會高於2023年公佈的15令吉。穩健的營收表現支持了息稅折舊攤銷前利潤的增長和強勁的現金產生。該集團預計,在投資組合增長的支持下,在2025年至2030年期間,運營產生的年現金流將達到48000萬至12令吉。

As at end-September 2024, SHH's borrowings stood at RM1.3 billion, with a debt-to-equity ratio of 0.45x. This is expected to decline slightly by year end to about RM1.0 billion following a scheduled debt repayment of approximately RM282 million. SHH forecasts borrowings in the range of between RM1.1 billion and RM1.7 billion from FY2025 to FY2030, with proceeds primarily funding the group's ongoing expansion plans. MARC Ratings believes the group's cash-generative operations will support the higher debt levels. Under the rating agency's sensitised case, which includes profitability stress, cash flow coverage on interest and debt is expected to remain strong at 7.9x-12.2x and 0.3x-0.4x over the forecast period.

截至2024年9月底,SHH的借款額爲13令吉,債務與權益比率爲0.45倍。在計劃償還約28200萬令吉的債務之後,預計到年底將略有下降至10令吉左右。SHH預測,從 FY2025 到 FY2030 的借款將在11令吉至17令吉之間,所得款項主要爲該集團正在進行的擴張計劃提供資金。MARC評級認爲,該集團的現金產生業務將支持更高的債務水平。根據該評級機構的敏感案例,包括盈利壓力,利息和債務的現金流覆蓋率預計將在預測期內保持強勁的7.9x12.2倍和0.3x-0.4倍。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論